Keynote Financial Services’s CVS Health CVS Stock Holding History

Keynote Financial Services’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Sell	28,624 -653	-2%	-$50.3K	1.09%	19
2025 Q4	$2.32M	Sell	29,277 -22	-0.1%	-$1.73K	1.3%	15
2025 Q3	$2.21M	Sell	29,299 -575	-2%	-$39.4K	1.33%	15
2025 Q2	$2.06M	Sell	29,874 -2,502	-8%	-$164K	1.39%	13
2025 Q1	$2.19M	Sell	32,376 -9	-0%	-$539	1.57%	13
2024 Q4	$1.45M	Buy	32,385 +4,034	+14%	+$226K	1.12%	23
2024 Q3	$1.78M	Buy	28,351 +3,320	+13%	+$194K	1.36%	15
2024 Q2	$1.48M	Buy	25,031 +1,168	+5%	+$73.1K	1.24%	21
2024 Q1	$1.9M	Buy	+23,863	New	+$1.82M	1.6%	11

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Keynote Financial Services's CVS Position: Q1 2026 in Review

Keynote Financial Services reduced its CVS Health (CVS) stake by 2.2% in Q1 2026, selling an estimated $50.3K and leaving 28,624 shares worth $2.06M. The position accounts for 1.09% of the portfolio, ranked #19.

Keynote Financial Services first reported a position in CVS in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.32M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Keynote Financial Services held 28,624 shares of CVS Health worth $2.06M as of Q1 2026.
Keynote Financial Services sold 653 CVS Health shares in Q1 2026, an estimated $50.3K.
CVS Health made up 1.09% of Keynote Financial Services's portfolio in Q1 2026, its #19 holding.
Keynote Financial Services first reported a position in CVS Health in Q1 2024 and has held it in 9 quarters since.
Keynote Financial Services's CVS Health position peaked at $2.32M in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.